The proposed research focuses on the development of innovative protocol of mismatched stem cell transplantation with combined 2 different haplo stem cell transplantation (SCT) donors which are mismatched to the recipient (and preferably to each other), in a patient in need for SCT, lacking an HLA match related or an unrelated donor. This innovative protocol named multi donor stem cell transplantation (MDT) is designed to facilitate engraftment even when reduced intensity conditioning or a low cell dose are used, improve the graft vs. leukemia (GVL) effect and enhance immune reconstitution (using quantitative and qualitative parameters).
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
10
stem cell transplantation from 2 donors
Hadassah Medical Organization
Jerusalem, Israel
RECRUITINGDay of neutrophil engraftment
Time frame: 30d
Day of platelet engraftment>20x10(9)L
Time frame: 30
Acute GVHD occurrence>2
Time frame: 100d
Disease free survival
Time frame: 100d
Day of platelet engraftment>50x10(9)/L
Time frame: 30d
Time of acute GVHD
Time frame: 100d
GVHD grade
Time frame: 100d
Overall survival
Time frame: 100 days
Infections incidence
Time frame: 100d
transplant-related mortality
Time frame: 100d
Transplant related toxicity
Time frame: 100d
Immune reconstitution
Time frame: 100d
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.